Member Info for JimiHendrix

Fantastic update! The NICE guidelines may come this week now that the study has been published sooner than expected.

The use of Genedrive’s POC testing in an emergency care setting is described as “entering a new era” and “an important step” in the management of neonatal sepsis. The PALOH study is now published

Lloyd, it's new news that it has now been published which which most believe is the precursor to NICE updating their guidance to say that the test must be used by the whole NHS.

Now published in JAMA Paediatrics The PALOH study, using the Genedrive® MT-RNR1 ID Kit to save infants from Antibiotic Induced Hearing Loss Congratulations to the PALOH team.

AIHL

Spot on TrickyMatters! This is an utterly fantastic price to be buying in at. Glad I'm in over the weekend too... lol

For anybody who missed Bill's interview... https://twitter.com/genedriveplc/status/1504747247673790477?s=20&t=07yK40smC2XQ47nqAlz_2Q

Bill's interview was excellent, really get a sense of the impact AIHL is going to have... things seem to be happening far quicker than expected. It's also very exciting to hear Bill talk about future genetic tests they are going to be researching for GPs to administer to their patients... for example one test he mentioned would test which kind of anti-depressant would be most suitable for their individual genetic makeup, and another test would do the same for painkillers.

Seems highly likely Genedrive would be involved in the development and commercialisation of these future genetic tests.

That’s not true RiskIsReward, they’re fully funded to role out AIHL in both UK and Europe which is their plans for this year. It’s the FDA they would need funds for however with sales looking like taking off sooner than expected in UK/Europe they will likely be able to use the income generated from those.

It’ll probably go down a bit under the directors buy price before rising further. Frustrating, but typical of all smallish mcap stocks. It’ll also encourage more buying from Bio at bargain prices :)

"We're excited to share findings from the #PALOH trial very soon. We'll be posting a link here as soon as the manuscript is live."

It'll arrive before the financial results I think.

If Bio had agreed anything with Nova then the director wouldn’t have been able to purchase shares recently as it would be insider information. My belief is he can see what Bio appear to be doing and like many are anticipating a significant rise in share price as they continue to buy up more of the free float. So a well timed buy imo.

I think it'll pick up again today, just initial profit taking. We know there's substance to the rise (POC sales and AIHL study & guidance).

It's been a long time since we've had so many ducks lined up.

• Covid starting to surge again
• Increasing concerns over new variant
• Apparent first sales of the long awaited POC
• Groundbreaking 4 year PALOH study to be published in the next couple of weeks, followed by NICE guidance
• Share price at all time lows
• Loads of cash in the bank

Looking excellent :)

Yep, could see a massive rise here with POC and AIHL now coming into the limelight.

It’s also worth noting how the market makers are making it very difficult to buy any stock at these levels. It was the same yesterday. After every buy it goes to NT, or says no quote available. This tells me it’s going to go up when they’re ready, or sooner if news is leaked or an RNS is released.

Once the wider market realises there appears to have been some POC sales, we will likely see a positive reaction. This is an exciting month with the PALOH study being published in the next couple of weeks, with NICE guidance waiting on it and apparent POC sales - at last :)

WHO sounds alarm on new variant as it spreads in Europe.

As a majority of the world begins to look past the pandemic, hoping that at some point this year they can safely start living alongside Covid without much worry day-to-day, the World Health Organization (WHO) warns that the 'Deltacron' variant - a stain of the virus that includes traits from both Delta and Omicron, is starting to spread across Europe.

The organization said during a briefing Wednesday that the strain has been found to be spreading in France, Holland and Denmark.

https://www.google.com/amp/s/news.sky.com/story/amp/covid-19-royal-cornwall-hospitals-suspend-all-visiting-after-significant-increase-in-patients-testing-positive-12562491

COVID-19: Royal Cornwall Hospital suspends all visiting after 'significant increase' in patients testing positive
A rise in cases in the county has prompted calls from public health teams for people to continue regularly testing and taking the necessary precautions to keep the virus "at bay".

So going by the information on the flyer each of those 61 batches contains a box of 25 tests. So 61x25 is 1525 tests. I’m unclear whether the £20-30 price is for a box of 25 tests, or the cost per individual test.